Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4757520
Max Phase: Preclinical
Molecular Formula: C44H39ClFN5O6S
Molecular Weight: 820.34
Molecule Type: Unknown
Associated Items:
ID: ALA4757520
Max Phase: Preclinical
Molecular Formula: C44H39ClFN5O6S
Molecular Weight: 820.34
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccccc1-c1nccc(COc2ccccc2C[C@@H](Oc2ncnc3sc(-c4ccc(F)cc4)c(-c4ccc(OCCN(C)C)c(Cl)c4C)c23)C(=O)O)n1
Standard InChI: InChI=1S/C44H39ClFN5O6S/c1-26-31(17-18-35(39(26)45)55-22-21-51(2)3)37-38-42(48-25-49-43(38)58-40(37)27-13-15-29(46)16-14-27)57-36(44(52)53)23-28-9-5-7-11-33(28)56-24-30-19-20-47-41(50-30)32-10-6-8-12-34(32)54-4/h5-20,25,36H,21-24H2,1-4H3,(H,52,53)/t36-/m1/s1
Standard InChI Key: QEJARSYZXAFQQG-PSXMRANNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 820.34 | Molecular Weight (Monoisotopic): 819.2294 | AlogP: 9.19 | #Rotatable Bonds: 16 |
Polar Surface Area: 129.02 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.12 | CX Basic pKa: 8.69 | CX LogP: 6.52 | CX LogD: 6.51 |
Aromatic Rings: 7 | Heavy Atoms: 58 | QED Weighted: 0.10 | Np Likeness Score: -0.88 |
1. Szlavik Z,Csekei M,Paczal A,Szabo ZB,Sipos S,Radics G,Proszenyak A,Balint B,Murray J,Davidson J,Chen I,Dokurno P,Surgenor AE,Daniels ZM,Hubbard RE,Le Toumelin-Braizat G,Claperon A,Lysiak-Auvity G,Girard AM,Bruno A,Chanrion M,Colland F,Maragno AL,Demarles D,Geneste O,Kotschy A. (2020) Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor., 63 (22): [PMID:33146521] [10.1021/acs.jmedchem.0c01234] |
Source(1):